RNTCP Annual Report 2012 - TBC India

P. K. PRADHAN
Secratary
Department of Health & FW
Tel: 23061863 Fax 23061252
e-mailL: secyhfw@nic.in
lR;eso t;rs
MESSAGE
Hkkjr ljdkj
LokLF; ,oa ifjokj dY;k.k ea=kky;
fuekZ.k Hkou] ubZ fnYyh&110108
Government of India
Ministry of Health & Family Welfare
Nirman Bhavan, New Delhi-110108
India has the highest burden of Tuberculosis in the world with over two million incident cases amounting to
more than fifth of global burden. Tuberculosis has been known to have devastating effects on the socioeconomic
development especially in the developing countries due to its association with dreaded disease like HIV/AIDS and
malnutrition in the poorest of the poor. Drug resistance, diabetes, smoking and other associated factors complicate TB
scenario further making it difficult to control tuberculosis.
Having treated 14.2 million TB cases, saving additional 2.6 million lives, Revised National Tuberculosis Control
Programme has moved beyond the objectives of 70% case detection rate and 85% cure rate in new smear positive
patients and has set new objective of 'Universal access to TB Care'.
After achieving complete nationwide coverage for implementation of DOTS in 2006, TB-HIV intensified
package, for management of TB-HIV co infected cases, has been made available to total population across the country
2011.
While, key focus of the programme is to prevent the emergence of drug resistance by provision of quality
DOTS services, the management of Multi Drug Resistant-TB (MDR-TB) patients is now an integral component of
RNTCP. 37 Culture and DST laboratories have been accredited nationwide to provide quality diagnostic services for
drug resistant TB cases. All 35 States/UTs have introduced Programatic Management of Drug-resistant TB Services
(PMDT) services in some districts with variable access and are being scaled up to achieve complete geographical
coverage by end of 2012.
Dramatic growth in information communication technology allows unprecedented opportunities to ensure
that TB cases are promptly diagnosed and optimally treated. This opportunity builds upon an existing strength of the
Programme in rigorous data collection and analysis, a spectrum of ongoing activities. Case based web enabled system
for recording and reporting of the TB case is being developed to enable better surveillance and tracking of TB cases.
Rational use of anti-TB drugs by every health care provider needs to be ensured. This responsibility when
exercised properly will prevent development of drug resistant Tuberculosis and will accelerate TB Control. The Govt
of India is committed for providing requisite resources for fighting both stigma and disease due to TB.
National Rural Health Mission
P. K. Pradhan